Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Bronstein, Gewirtz & Grossman, LLC Encourages Elicio Therapeutics, Inc. (ELTX) Investors to Inquire about Securities Investigation

accessnewswire.com

Bronstein, Gewirtz & Grossman, LLC Encourages Elicio Therapeutics, Inc. (ELTX) Investors to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / June 26, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elicio Therapeutics, Inc. ("Elicio" or "the Company") (NASDAQ:ELTX). Investors who purchased Elicio securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ELTX.

Elicio Investigation Details

On June 15, 2026, Elicio announced results of its Phase 2 AMPLIFY-7P study. According to the Company, "AMPLIFY-7P did not meet the pre-specified primary endpoint of disease-free survival ("DFS") in the intent-to-treat population." Following this news, Elicio's shares fell by almost 71% on the same day.

What's Next for Elicio Investors?

If you are aware of any facts relating to this investigation or purchased Elicio securities, you can assist this investigation by visiting the firm's site: bgandg.com/ELTX. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911

No Cost to Elicio Investors

We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Elicio Securities Investigation?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE: Bronstein, Gewirtz & Grossman, LLC